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Fig. S1. Effect of expression system on antigenicity and glycosylation of BG505 Env trimers. Table S1 . X-ray data collection and refinement statistics. Crystal structure of clade B tier 3 H078.14 UFO-BG trimer bound to bNAbs PGT124 and 35O22 at 4.6 Å resolution. A 2Fo-Fc electron density map (contoured at 1.0 ) showing gp120 (in yellow backbone tube model) and gp41 ECTO (in green backbone tube model) of the H078.14 UFO-BG protomer in the crystal asymmetric unit bound to PGT124 (grey and pink) and 35O22 (cyan and magenta). (B) Negative-stain EM of UFO-BG trimers produced in ExpiCHO cells followed by GNL and SEC purification. The full sets of reference-free 2D class averages are shown for clade A BG505 (tier 2) and Q842-d12 (tier 2), clade B 6240.08.TA5.4622 (tier 2) and H078.14 (tier 2), clade C Du172.17 (tier 2) and 16055-2.3 (tier 2), clade B/C CH115.12 (tier 3) and clade A/E 93JP_NH1. The percentage of native-like trimers is indicated below each panel. Thermal stability of four UFO-BG-FR nanoparticles derived from three subtypes by differential scanning calorimetry (DSC). Three thermal parameters (T m , T 1/2 and T onset ) are labeled on the DSC profiles. Data fitting was performed using the standard software provided by the vendor. The raw data and the fitted curve are plotted as black dotted lines and red lines, respectively. (C) Antigenic profiles of UFO-BG-FR nanoparticles derived from five subtypes evaluated against a panel of six bNAbs and four non-NAbs. Sensorgrams were obtained from an Octet RED96 instrument using a titration series of 6 concentrations (starting at 35 nM by 2-fold dilution). The strains tested here include clade A Q842-d12 (tier 2), clade B H078.14 (tier 2), clade C Du172.17 (tier 2), clade B/C CH115.12 (tier 3), and clade A/E 93JP_NH1. (D) Sequence alignment of I3-01 (PDBID: 5KP9) and 2-dehydro-3-deoxyphosphogluconate aldolase/4-hydroxy-2-oxoglutarate aldolase (TM0066) from Thermotoga maritima (PDBID: 1VLW), with the five amino acids that differ in the two sequences colored in red and the 11 amino acids at the I3-01 particle-forming interface highlighted in yellow. (E) Sequences of ten 1VLW variants (1VLW-V i , i=1 to 10) by altering amino acids at the corresponding I3-01 particle-forming interface. (F) SEC profiles of ten BG505 gp140.664.R1-PADRE-1VLW-V i constructs obtained from a Superose 6 10/300 GL column. The fusion constructs were expressed in ExpiCHO cells and purified using a 2G12 affinity column.
Fig. S7. B cell activation and in vivo evaluation of gp41 ECTO -stabilized trimers and nanoparticles. (A) Ca
2+ mobilization in B cell transfectants carrying PGT145, PGT121, and VRC01 bNAb receptors. WEHI231 cells expressing a doxycyclin-inducible form of bNAb B cell receptor (BCR) were stimulated with anti-BCR antibodies or the indicated antigens at a concentration of 10 g ml -1 : anti-human Ig -chain F(ab') 2 ; anti-mouse IgM; an UFO-BG trimer derived from a clade A, B, C, B/C, or A/E strain, or a gp140-PADRE construct containing a redesigned HR1 bend within gp41 ECTO . (B) Testing gp41 ECTO -stabilized BG505 trimer and nanoparticle immunogens in mice and ELISA binding of purified mouse IgGs to three HIV-1 antigens, including a BG505 UFO trimer, an N332 supersite probe based on ferritin nanoparticle (1GUT_A_ES-FR) or I3-01 nanoparticle (1KIG_L_ES-2-I3-01), and a V1V2 apex probe based on ferritin nanoparticle (clade C V1V2-FR). EC 50 values are labeled for all ELISA plots except for instances in which the highest OD 450 value is below 0.1 or in cases of ambiguous data fitting. (C) HIV-1 neutralization by group-combined mouse IgGs, with IC 50 s color-coded according to the value ranging from green (weak neutralization) to red (potent neutralization). (D) ELISA binding of rabbit plasma to BG505 UFO trimer and an I3-01 nanoparticle presenting 60 N332 scaffolds (1KIG_L_ES-2-I3-01). The heat-inactivated plasma was diluted by 50-fold and subjected to a 10-fold dilution series in the assay. EC 50 binding antibody titers are labeled for all plots except for the time point of day -10 (-d10). (E) Neutralization of clade A tier 2 BG505.T332N and clade B tier 1 SF162 by rabbit plasma. The heat-inactivated plasma was diluted by 50-fold and subjected to a 3-fold dilution series in the TZM-bl assay. ID 50 NAb titers are labeled for all plots except for the time points of day -10 (-d10) and week 1 (w1), as well as week 6 (w6) for the trimer group tested against BG505.T332N. In (D) and (E), samples obtained from eight rabbits in the trimer group (34, 35, 36, and 37) and the ferritin group (62, 63, 64, and 65) at the time points of day -10 (-d10) and weeks 1, 6, 14, 22, and 30 (w1, w6, w14, w22, and w30) were analyzed in ELISA and neutralization assays. (F) Neutralization of 12 isolates in the global panel by rabbit plasma from the trimer group. (G) Neutralization of 12 isolates in the global panel by rabbit plasma from the ferritin group. In (F) and (G), samples at day -10 (-d10) and week 22 (w22) were analyzed to examine plasma neutralization of heterologous HIV-1 clones. To increase the sensitivity of detection, rabbit plasma was diluted by 20-fold followed by a 3-fold dilution series in TZM-bl assays. To reduce false positives caused by non-specific antiviral proteins present in the rabbit plasma, a simple metric was utilized that directly compares the percent neutralization of the w22 sample to that of the -d10 sample from the same animal at the 20-and 60-fold dilutions. The w22 signals at both dilutions must be 2-fold greater than the corresponding -d10 signals for a sample to be considered neutralizing a virus clone in the global panel. By this metric, the w22 samples in both trimer and ferritin groups neutralized p398F1 (clade A), p25710 (clade C), pX2278 (clade B), and pCNE8 (clade A/E) among others. ID 50 NAb titers are only labeled for p398F1, for which 60-80% neutralization was observed for w22 compared to -d10, approaching ID 50 values observed for the autologous neutralization. 
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